New Guidelines on MRI Safety and Compatibility of Medical Devices
By MedImaging International staff writers Posted on 13 Jan 2015 |
Image: Endovascular grafts, such as W.L. Gore’s TAG thoracic endoprosthesis, are among the “passive” implants subject to the new guidance (Photo courtesy of Gore Medical).
The US Food and Drug Administration issued new guidance recommendations on magnetic resonance imaging (MRI) compatibility—or in some instances, incompatibility—of implants that do not require electricity to service their function, such as intracranial aneurysm clips, cardiovascular stents, endovascular grafts, and transprostatic tissue retractors.
The topic of MRI-safe devices, up to now, has mostly centered on devices such as pacemakers, and more recently cochlear implants, both of which use electronics. Now, however, the FDA (Silver Spring, MD, USA) has three principal concerns about patient safety in regards to these so-called “passive” implants in the MRI setting: the displacement forces and torques on magnetic substances, which can turn devices into deadly projectiles; radiofrequency heating that can burn patients; and the distorting effect of implants upon an MRI scan. The FDA recommends four tests described by standard setting institution, American Society for Testing and Materials (ASTM) International, to tackle these three safety issues, and provides additional details about the way those tests should be performed. For example, the guidance reported that “the testing should encompass the range of sizes of the device you intend to market.”
MRI scans are provided in various magnetic field strengths, measured in Teslas. “Although commercial 1.5 T MR systems are currently the most common, 3 T MR systems are becoming more common. A medical device that is classified as MR Conditional in a 1.5 T scanner may not be safe to scan in an MR system with a higher or lower field strength,” the guidance cautioned.
The implant’s labeling should describe the device as “MR Safe,” “MR Unsafe,” or “MR Conditional,” as defined by ASTM International in standard F2503-13. Lastly, the fourth category, “Safety in MRI Not Evaluated,” may be suitable in some instances, but not for those passive implants that are known to present MRI compatibility issues, are a new device type or contain ferromagnetic materials.
Related Links:
US Food and Drug Administration
The topic of MRI-safe devices, up to now, has mostly centered on devices such as pacemakers, and more recently cochlear implants, both of which use electronics. Now, however, the FDA (Silver Spring, MD, USA) has three principal concerns about patient safety in regards to these so-called “passive” implants in the MRI setting: the displacement forces and torques on magnetic substances, which can turn devices into deadly projectiles; radiofrequency heating that can burn patients; and the distorting effect of implants upon an MRI scan. The FDA recommends four tests described by standard setting institution, American Society for Testing and Materials (ASTM) International, to tackle these three safety issues, and provides additional details about the way those tests should be performed. For example, the guidance reported that “the testing should encompass the range of sizes of the device you intend to market.”
MRI scans are provided in various magnetic field strengths, measured in Teslas. “Although commercial 1.5 T MR systems are currently the most common, 3 T MR systems are becoming more common. A medical device that is classified as MR Conditional in a 1.5 T scanner may not be safe to scan in an MR system with a higher or lower field strength,” the guidance cautioned.
The implant’s labeling should describe the device as “MR Safe,” “MR Unsafe,” or “MR Conditional,” as defined by ASTM International in standard F2503-13. Lastly, the fourth category, “Safety in MRI Not Evaluated,” may be suitable in some instances, but not for those passive implants that are known to present MRI compatibility issues, are a new device type or contain ferromagnetic materials.
Related Links:
US Food and Drug Administration
Latest MRI News
- Low-Cost Whole-Body MRI Device Combined with AI Generates High-Quality Results
- World's First Whole-Body Ultra-High Field MRI Officially Comes To Market
- World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer